Literature DB >> 23002438

Cysteinyl leukotriene 2 receptor on dendritic cells negatively regulates ligand-dependent allergic pulmonary inflammation.

Nora A Barrett1, James M Fernandez, Akiko Maekawa, Wei Xing, Li Li, Matthew W Parsons, K Frank Austen, Yoshihide Kanaoka.   

Abstract

Cysteinyl leukotrienes (cys-LTs) can mediate Th2 immunity to the house dust mite, Dermatophagoides farinae, via the type 1 receptor CysLT(1)R on dendritic cells (DCs). However, the role of the homologous type 2 receptor CysLT(2)R in Th2 immunity is unknown. D. farinae sensitization and challenge of CysLT(2)R-deficient mice showed a marked augmentation of eosinophilic pulmonary inflammation, serum IgE, and Th2 cytokines. Wild-type (WT) mice sensitized by adoptive transfer of D. farinae-pulsed CysLT(2)R-deficient bone marrow-derived DCs (BMDCs) also had a marked increase in D. farinae-elicited eosinophilic lung inflammation and Th2 cytokines in restimulated hilar nodes. This response was absent in mice sensitized with D. farinae-pulsed BMDCs lacking leukotriene C(4) synthase (LTC(4)S), CysLT(1)R, or both CysLT(2)R/LTC(4)S, suggesting that CysLT(2)R negatively regulates LTC(4)S- and CysLT(1)R-dependent DC-mediated sensitization. CysLT(2)R-deficient BMDCs had increased CysLT(1)R-dependent LTD(4)-induced ERK phosphorylation, whereas N-methyl LTC(4) activation of CysLT(2)R on WT BMDCs reduced such signaling. Activation of endogenously expressed CysLT(1)R and CysLT(2)R occurred over an equimolar range of LTD(4) and N-methyl LTC(4), respectively. Although the baseline expression of cell surface CysLT(1)R was not increased on CysLT(2)R-deficient BMDCs, it was upregulated at 24 h by a pulse of D. farinae, compared with WT or CysLT(2)R/LTC(4)S-deficient BMDCs. Importantly, treatment with N-methyl LTC(4) reduced D. farinae-induced CysLT(1)R expression on WT BMDCs. Thus, CysLT(2)R negatively regulates the development of cys-LT-dependent Th2 pulmonary inflammation by inhibiting both CysLT(1)R signaling and D. farinae-induced LTC(4)S-dependent cell surface expression of CysLT(1)R on DCs. Furthermore, these studies highlight how the biologic activity of cys-LTs can be tightly regulated by competition between these endogenously expressed receptors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23002438      PMCID: PMC3478400          DOI: 10.4049/jimmunol.1201865

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

Review 1.  Regulation of G protein-coupled receptor export trafficking.

Authors:  Chunmin Dong; Catalin M Filipeanu; Matthew T Duvernay; Guangyu Wu
Journal:  Biochim Biophys Acta       Date:  2006-09-23

2.  A functional G300S variant of the cysteinyl leukotriene 1 receptor is associated with atopy in a Tristan da Cunha isolate.

Authors:  Miles D Thompson; Valérie Capra; Jun Takasaki; Giovanna Maresca; G Enrico Rovati; Aurther S Slutsky; Craig Lilly; Noe Zamel; W McIntyre Burnham; David E Cole; Katherine A Siminovitch
Journal:  Pharmacogenet Genomics       Date:  2007-07       Impact factor: 2.089

Review 3.  The leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implications.

Authors:  K Frank Austen; Akiko Maekawa; Yoshihide Kanaoka; Joshua A Boyce
Journal:  J Allergy Clin Immunol       Date:  2009-08-03       Impact factor: 10.793

4.  GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4.

Authors:  Akiko Maekawa; Barbara Balestrieri; K Frank Austen; Yoshihide Kanaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-26       Impact factor: 11.205

5.  Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice.

Authors:  Thomas C Beller; Akiko Maekawa; Daniel S Friend; K Frank Austen; Yoshihide Kanaoka
Journal:  J Biol Chem       Date:  2004-08-24       Impact factor: 5.157

6.  Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants.

Authors:  T Benned-Jensen; M M Rosenkilde
Journal:  Br J Pharmacol       Date:  2010-02-08       Impact factor: 8.739

7.  A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells.

Authors:  Stephanie Dillon; Anshu Agrawal; Thomas Van Dyke; Gary Landreth; Laurie McCauley; Amy Koh; Charles Maliszewski; Shizuo Akira; Bali Pulendran
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

8.  CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells.

Authors:  Yongfeng Jiang; Laura A Borrelli; Yoshihide Kanaoka; Brian J Bacskai; Joshua A Boyce
Journal:  Blood       Date:  2007-08-10       Impact factor: 22.113

Review 9.  G protein-coupled receptor dimerisation: molecular basis and relevance to function.

Authors:  Graeme Milligan
Journal:  Biochim Biophys Acta       Date:  2006-09-30

10.  Alarming dendritic cells for Th2 induction.

Authors:  Andrew S MacDonald; Rick M Maizels
Journal:  J Exp Med       Date:  2008-01-14       Impact factor: 14.307

View more
  17 in total

1.  Dectin-2 regulates the effector phase of house dust mite-elicited pulmonary inflammation independently from its role in sensitization.

Authors:  Matthew W Parsons; Li Li; Aaron M Wallace; Min Jung Lee; Howard R Katz; James M Fernandez; Shinobu Saijo; Yoichiro Iwakura; K Frank Austen; Yoshihide Kanaoka; Nora A Barrett
Journal:  J Immunol       Date:  2014-01-22       Impact factor: 5.422

2.  Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation.

Authors:  Sean J Lund; Alex Portillo; Kellen Cavagnero; Rachel E Baum; Luay H Naji; Jana H Badrani; Amit Mehta; Michael Croft; David H Broide; Taylor A Doherty
Journal:  J Immunol       Date:  2017-06-30       Impact factor: 5.422

3.  Sickle erythrocytes and platelets augment lung leukotriene synthesis with downregulation of anti-inflammatory proteins: relevance in the pathology of the acute chest syndrome.

Authors:  Michael Opene; Joseph Kurantsin-Mills; Sumair Husain; Basil O Ibe
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

4.  Cysteinyl leukotriene 2 receptor promotes endothelial permeability, tumor angiogenesis, and metastasis.

Authors:  Ernest Duah; Lakshminarayan Reddy Teegala; Vinay Kondeti; Ravi K Adapala; Venkateshwar G Keshamouni; Yoshihide Kanaoka; K Frank Austen; Charles K Thodeti; Sailaja Paruchuri
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-17       Impact factor: 11.205

Review 5.  Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7.

Authors:  Magnus Bäck; William S Powell; Sven-Erik Dahlén; Jeffrey M Drazen; Jilly F Evans; Charles N Serhan; Takao Shimizu; Takehiko Yokomizo; G Enrico Rovati
Journal:  Br J Pharmacol       Date:  2014-07-12       Impact factor: 8.739

Review 6.  Leukotriene receptors as potential therapeutic targets.

Authors:  Takehiko Yokomizo; Motonao Nakamura; Takao Shimizu
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

7.  Phosphoinositide 3-Kinase δ Regulates Dectin-2 Signaling and the Generation of Th2 and Th17 Immunity.

Authors:  Min Jung Lee; Eri Yoshimoto; Shinobu Saijo; Yoichiro Iwakura; Xin Lin; Howard R Katz; Yoshihide Kanaoka; Nora A Barrett
Journal:  J Immunol       Date:  2016-05-18       Impact factor: 5.422

Review 8.  Lipid mediators and allergic diseases.

Authors:  Laura B Fanning; Joshua A Boyce
Journal:  Ann Allergy Asthma Immunol       Date:  2013-07-21       Impact factor: 6.347

Review 9.  Pathogenesis of aspirin-exacerbated respiratory disease and reactions.

Authors:  Tanya M Laidlaw; Joshua A Boyce
Journal:  Immunol Allergy Clin North Am       Date:  2012-12-23       Impact factor: 3.479

10.  Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway.

Authors:  Tao Liu; Yoshihide Kanaoka; Nora A Barrett; Chunli Feng; Denise Garofalo; Juying Lai; Kathleen Buchheit; Neil Bhattacharya; Tanya M Laidlaw; Howard R Katz; Joshua A Boyce
Journal:  J Immunol       Date:  2015-09-04       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.